Advances of MUC1 as a target for breast cancer immunotherapy

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/27626

RefMan EndNote BibTex RefWorks Excel CSV PDF Mendeley

Registro completo de metadatos

Campo DC	Valor	Lengua/Idioma
dc.contributor.author	Yang, E.	es
dc.contributor.author	Hu, X.F.	es
dc.contributor.author	Xing, P.X.	-
dc.date.accessioned	2012-05-21T12:10:42Z	-
dc.date.available	2012-05-21T12:10:42Z	-
dc.date.issued	2007	-
dc.identifier.issn	0213-3911	es
dc.identifier.uri	http://hdl.handle.net/10201/27626	-
dc.description.abstract	MUC1 is a potential target in breast cancer immunotherapy as MUC1 is overexpressed in breast cancer, and is absent or expressed in low level in normal mammary gland. In addition, MUC1 is mostly aberrantly underglycosylated in cancer and the antigens on the cancer surface are different from normal cell. Therefore targeting MUC1 for cancer immunotherapy can exploit the difference between cancer and normal cells, and eliminating the cancerous cells while leaving the normal mammary cells unharmed. This review will focus on the recent advance of MUC1 breast cancer immunotherapy currently being investigated.	es
dc.format	application/pdf	es
dc.format.extent	17	es
dc.language	eng	es
dc.publisher	Murcia : F. Hernández	es
dc.relation.ispartof	Histology and histopathology	es
dc.rights	info:eu-repo/semantics/openAccess	es
dc.subject	Immunotherapy	es
dc.subject	Breast cancer	es
dc.subject.other	616 - Patología. Medicina clínica. Oncología	es
dc.title	Advances of MUC1 as a target for breast cancer immunotherapy	es
dc.type	info:eu-repo/semantics/article	es
Aparece en las colecciones:	Vol.22, nº 8 (2007)

Ficheros en este ítem:

Fichero	Descripción	Tamaño	Formato
Advances of MUC1 as a target for breast cancer immunotherapy.pdf		378,3 kB	Adobe PDF	Visualizar/Abrir